Homocysteine: a futile comeback or a promising tool for the risk assessment of hypertensive patients?

Eur J Prev Cardiol. 2024 Jul 23;31(9):1090-1091. doi: 10.1093/eurjpc/zwae053.

Marco Bernardi¹, Francesco Paneni^{2

3}, Pierre Sabouret^{4

5}

¹ Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
² Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich 8091, Switzerland.
³ Center for Translational and Experimental Cardiology (CTEC), University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.
⁴ Heart Institute, Cardiology Department, Pitié-Salpétrière Hospital, Sorbonne University, 47-83 Bd de l'Hôpital, Paris 75013, France.
⁵ Cardiology Department, National College of French Cardiologists, 13 rue Niepce, 75014 Paris, France.

No abstract available

Publication types